Literature DB >> 18081815

Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia.

J Sträter, C Wiesmüller, S Perner, R Kuefer, P Möller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18081815     DOI: 10.1111/j.1365-2559.2007.02923.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  5 in total

1.  AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.

Authors:  Sotiris Lakis; Theodora Papamitsou; Constantina Panagiotopoulou; Rodoula Kotakidou; Vassiliki Kotoula
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Defining Cancer Risk in Barrett's Esophagus: A Pathologist's Perspective.

Authors:  Amy E Noffsinger
Journal:  Gastrointest Cancer Res       Date:  2008-11

Review 3.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802

4.  Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1.

Authors:  Dipti M Karamchandani; Heather L Lehman; Sara E Ohanessian; Julie Massé; Patricia A Welsh; Robert D Odze; John R Goldblum; Arthur S Berg; Douglas B Stairs
Journal:  Diagn Pathol       Date:  2016-02-29       Impact factor: 2.644

Review 5.  Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.

Authors:  Ksenia S Maslyonkina; Alexandra K Konyukova; Darya Y Alexeeva; Mikhail Y Sinelnikov; Liudmila M Mikhaleva
Journal:  Cancer Med       Date:  2021-12-06       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.